Flexion Therapeutics Inc 4
4 · Flexion Therapeutics Inc · Filed Apr 5, 2017
Insider Transaction Report
Form 4
Deniz Yamo
Chief Medical Officer
Transactions
- Award
Stock option (right to buy)
2017-04-03+150,000→ 150,000 totalExercise: $27.43Exp: 2027-04-02→ Common Stock (150,000 underlying)
Footnotes (1)
- [F1]Twenty-five percent (25%) of the shares subject to the option shall vest on April 3, 2018; thereafter one-forty-eighth (1/48th) of the shares subject to the option shall vest each month following April 3, 2018, so that all of the shares subject to the option shall be vested after April 3, 2021.